BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32141653)

  • 1. Lack of Asymmetry of Nigrostriatal Dopaminergic Function in Healthy Subjects.
    Garrido A; Iranzo A; Stefani A; Serradell M; Muñoz-Lopetegi A; Marrero P; Högl B; Gaig C; Santamaria J; Tolosa E; Poewe W;
    Mov Disord; 2020 Jun; 35(6):1072-1076. PubMed ID: 32141653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left-hemispheric predominance of nigrostriatal deficit in isolated REM sleep behavior disorder.
    Iranzo A; Stefani A; Niñerola-Baizan A; Stokner H; Serradell M; Vilas D; Holzknecht E; Gaig C; Pavia J; Lomeña F; Reyes D; Seppi K; Santamaria J; Högl B; Tolosa E; Poewe W;
    Neurology; 2020 Apr; 94(15):e1605-e1613. PubMed ID: 32161031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dopamine transporter degeneration in right-handed REM sleep behavior disorder patients progresses faster in the left hemisphere.
    Miyamoto T; Akaiwa Y; Numahata K; Yoshizawa K; Sairenchi T; Miyamoto M
    Parkinsonism Relat Disord; 2022 Feb; 95():107-112. PubMed ID: 35093712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder.
    Kim YK; Yoon IY; Kim JM; Jeong SH; Kim KW; Shin YK; Kim BS; Kim SE
    Eur J Neurol; 2010 Mar; 17(3):487-92. PubMed ID: 19968708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
    Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
    Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
    Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
    Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T
    J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls.
    Eisensehr I; Linke R; Tatsch K; Kharraz B; Gildehaus JF; Wetter CT; Trenkwalder C; Schwarz J; Noachtar S
    Sleep; 2003 Aug; 26(5):507-12. PubMed ID: 12938802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
    Walker Z; Costa DC; Walker RW; Lee L; Livingston G; Jaros E; Perry R; McKeith I; Katona CL
    Neurology; 2004 May; 62(9):1568-72. PubMed ID: 15136683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease.
    Scherfler C; Seppi K; Mair KJ; Donnemiller E; Virgolini I; Wenning GK; Poewe W
    Brain; 2012 Nov; 135(Pt 11):3348-54. PubMed ID: 23043142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the availability of dopamine transporter and olfactory function in healthy subjects.
    Pak K; Kim K; Lee MJ; Lee JM; Kim BS; Kim SJ; Kim IJ
    Eur Radiol; 2018 Apr; 28(4):1756-1760. PubMed ID: 29164380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
    Arnaldi D; De Carli F; Picco A; Ferrara M; Accardo J; Bossert I; Famà F; Girtler N; Morbelli S; Sambuceti G; Nobili F
    Neurobiol Aging; 2015 Dec; 36(12):3300-3305. PubMed ID: 26410306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.
    Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Tanaka K
    Brain; 2001 Apr; 124(Pt 4):784-92. PubMed ID: 11287377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
    Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS
    J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
    Arnaldi D; Chincarini A; Hu MT; Sonka K; Boeve B; Miyamoto T; Puligheddu M; De Cock VC; Terzaghi M; Plazzi G; Tachibana N; Morbelli S; Rolinski M; Dusek P; Lowe V; Miyamoto M; Figorilli M; Verbizier D; Bossert I; Antelmi E; Meli R; Barber TR; Trnka J; Miyagawa T; Serra A; Pizza F; Bauckneht M; Bradley KM; Zogala D; McGowan DR; Jordan L; Manni R; Nobili F
    Brain; 2021 Feb; 144(1):278-287. PubMed ID: 33348363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Susceptibility Associates With Dopaminergic Deficits and Cognition in Parkinson's Disease.
    Uchida Y; Kan H; Sakurai K; Inui S; Kobayashi S; Akagawa Y; Shibuya K; Ueki Y; Matsukawa N
    Mov Disord; 2020 Aug; 35(8):1396-1405. PubMed ID: 32369660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson's Disease Subtypes.
    Knudsen K; Fedorova TD; Horsager J; Andersen KB; Skjærbæk C; Berg D; Schaeffer E; Brooks DJ; Pavese N; Van Den Berge N; Borghammer P
    J Parkinsons Dis; 2021; 11(4):1677-1687. PubMed ID: 34334424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.
    Vriend C; Raijmakers P; Veltman DJ; van Dijk KD; van der Werf YD; Foncke EM; Smit JH; Berendse HW; van den Heuvel OA
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):159-64. PubMed ID: 23813742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients.
    Kim KW; Jhoo JH; Lee SB; Lee SD; Kim TH; Kim SE; Kim YK; Yoon IY
    Eur J Neurol; 2012 Sep; 19(9):1213-8. PubMed ID: 22435397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.